CN105017403A - 胰腺癌相关多肽dap44单克隆抗体的制备及其应用 - Google Patents
胰腺癌相关多肽dap44单克隆抗体的制备及其应用 Download PDFInfo
- Publication number
- CN105017403A CN105017403A CN201510400228.4A CN201510400228A CN105017403A CN 105017403 A CN105017403 A CN 105017403A CN 201510400228 A CN201510400228 A CN 201510400228A CN 105017403 A CN105017403 A CN 105017403A
- Authority
- CN
- China
- Prior art keywords
- dap44
- antibody
- monoclonal antibody
- antigen
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510400228.4A CN105017403B (zh) | 2015-07-09 | 2015-07-09 | 胰腺癌相关多肽dap44单克隆抗体的制备及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510400228.4A CN105017403B (zh) | 2015-07-09 | 2015-07-09 | 胰腺癌相关多肽dap44单克隆抗体的制备及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105017403A true CN105017403A (zh) | 2015-11-04 |
CN105017403B CN105017403B (zh) | 2018-07-03 |
Family
ID=54407747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510400228.4A Active CN105017403B (zh) | 2015-07-09 | 2015-07-09 | 胰腺癌相关多肽dap44单克隆抗体的制备及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105017403B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110297090A (zh) * | 2019-05-31 | 2019-10-01 | 荆州市第一人民医院 | 一种用于评价子宫内膜腺癌恶性程度的试剂盒 |
CN112300283A (zh) * | 2019-07-29 | 2021-02-02 | 深圳华大生命科学研究院 | 一种抗人胰腺癌单克隆抗体及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004031412A2 (en) * | 2002-09-30 | 2004-04-15 | Oncotherapy Science, Inc. | Method for diagnosing pancreatic cancer |
WO2004065547A2 (en) * | 2003-01-17 | 2004-08-05 | The Research Foundation Of The State University Of New York | Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
CN101204586A (zh) * | 2007-12-13 | 2008-06-25 | 中国科学院遗传与发育生物学研究所 | Dysbindin及其编码基因在筛选预防和/或治疗精神***症药物中的应用 |
CN103773737A (zh) * | 2014-01-15 | 2014-05-07 | 东北林业大学 | 抗ca199单克隆抗体产生的杂交瘤及化学发光免疫分析试剂盒的制备 |
-
2015
- 2015-07-09 CN CN201510400228.4A patent/CN105017403B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004031412A2 (en) * | 2002-09-30 | 2004-04-15 | Oncotherapy Science, Inc. | Method for diagnosing pancreatic cancer |
WO2004065547A2 (en) * | 2003-01-17 | 2004-08-05 | The Research Foundation Of The State University Of New York | Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
CN101204586A (zh) * | 2007-12-13 | 2008-06-25 | 中国科学院遗传与发育生物学研究所 | Dysbindin及其编码基因在筛选预防和/或治疗精神***症药物中的应用 |
CN103773737A (zh) * | 2014-01-15 | 2014-05-07 | 东北林业大学 | 抗ca199单克隆抗体产生的杂交瘤及化学发光免疫分析试剂盒的制备 |
Non-Patent Citations (1)
Title |
---|
UNIPROTKB: "D6RAX1_HUMAN", 《UNIPROTKB》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110297090A (zh) * | 2019-05-31 | 2019-10-01 | 荆州市第一人民医院 | 一种用于评价子宫内膜腺癌恶性程度的试剂盒 |
CN112300283A (zh) * | 2019-07-29 | 2021-02-02 | 深圳华大生命科学研究院 | 一种抗人胰腺癌单克隆抗体及其制备方法和应用 |
CN112300283B (zh) * | 2019-07-29 | 2024-01-02 | 深圳华大生命科学研究院 | 一种抗人胰腺癌单克隆抗体及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105017403B (zh) | 2018-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101854946B (zh) | 结肠癌和胰腺癌的重组单克隆抗体和相应抗原 | |
CN102245767B (zh) | 人cxcl1蛋白质的免疫学测定方法 | |
CA2682296A1 (en) | Anti-epcam antibody and uses thereof | |
CN116693681B (zh) | 抗幽门螺杆菌细胞毒素相关蛋白a的单克隆抗体及其应用 | |
CN106164672A (zh) | 用于诊断的细胞表面***癌抗原 | |
CN108341876A (zh) | 抗人ceacam5单克隆抗体及其制备方法和应用 | |
CN107001437A (zh) | 卵巢透明细胞腺癌的检查方法及检查药 | |
CN105017403B (zh) | 胰腺癌相关多肽dap44单克隆抗体的制备及其应用 | |
CN101302254B (zh) | 抗肝癌源性生长因子单克隆抗体及其应用 | |
CN104894074A (zh) | 分泌s100a9单克隆抗体的杂交瘤细胞株、单克隆抗体及其应用 | |
CN107298697A (zh) | 一种人pd‑l1蛋白y123位点磷酸化抗体及其制备方法和应用 | |
KR101263913B1 (ko) | 우결핵 진단 키트 및 이를 이용한 우결핵 진단 방법 | |
DE68928106T2 (de) | Nachweis, quantifizierung und klassifizierung von ras-proteinen in körperflüssigkeiten und geweben | |
JPWO2009044561A1 (ja) | 抗proNT/NMNモノクローナル抗体 | |
US7097846B2 (en) | 35 kD tumor associated protein antigen: uses and methods of detection | |
US9273127B2 (en) | P28GANK monoclonal antibody and peptides for preparation thereof and use thereof | |
CN106434565B (zh) | 一株杂交瘤细胞株及其产生的抗磷酸化aeg‑1的单克隆抗体与应用 | |
CN110760482B (zh) | 一株分泌抗CLas膜蛋白Cmp1单克隆抗体的杂交瘤细胞株5A4及单克隆抗体和应用 | |
CN114106169B (zh) | 一种针对抗REGγ全长蛋白的重组单克隆抗体及其制备方法和应用 | |
CN117467004B (zh) | 抗人钙网膜蛋白的兔单克隆抗体及其应用 | |
CN110713985B (zh) | 一株分泌抗CLas膜蛋白Cmp1单克隆抗体的杂交瘤细胞株5H4及单克隆抗体和应用 | |
US5262523A (en) | Antibodies reactive with normal and oncogenic forms of the ras p21 protein | |
CN101270161A (zh) | 抗人Reg4的单克隆抗体及其制备与应用以及杂交瘤细胞株 | |
CN115505574A (zh) | 一种分泌抗CLas分泌蛋白R1g单克隆抗体的杂交瘤细胞株R1g1 4B4及应用 | |
CN102234633B (zh) | 一种人泛素偶联酶UbcH10单克隆抗体杂交瘤DY02及单克隆抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Yong Inventor after: Fang Cheng Inventor after: Bai Quan Inventor after: Yao Xuebiao Inventor after: Zhao Ning Inventor after: Guo Xin Inventor after: Lv Xing Inventor before: Chen Yong Inventor before: Bai Quan Inventor before: Yao Xuebiao Inventor before: Zhao Ning Inventor before: Fang Cheng Inventor before: Guo Xin Inventor before: Lv Xing |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Yong Inventor after: Fang Cheng Inventor after: Bai Quan Inventor after: Yao Xuebiao Inventor after: Zhao Ning Inventor after: Guo Xin Inventor after: Lv Xing Inventor before: Chen Yong Inventor before: Fang Cheng Inventor before: Bai Quan Inventor before: Yao Xuebiao Inventor before: Zhao Ning Inventor before: Guo Xin Inventor before: Lv Xing |
|
CB03 | Change of inventor or designer information |